medac GmbH for Clinical Special Preparations
PolandAll drugs from this manufacturer
-
The medicine is used to treat several types of bladder cancer (when the tumor is limited to the cells lining the inner surface of the bladder) and to prevent its recurrence.
Dosage form: powder and solvent for preparation of suspension for bladder
Active substance Dosage live bcg cells min. 2x10^8 max. 3x10^9 ATC: L03AX03
-
The medicinal product is used for the treatment of chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine 26.1 mg ATC: L01AA09
-
The drug is used in the treatment of head and neck cancers, cervical cancer, and external genital cancers, Hodgkin's disease and non-Hodgkin lymphomas, testicular cancer, and in cases of pleural effusion caused by cancer.
Dosage form: powder for preparation of injection solution
Active substance Dosage bleomycin sulfate 15000 j.m. ATC: L01DC01
-
The medicinal product is used in the treatment of certain types of ovarian cancer (epithelial origin) and lung cancer (small cell).
Dosage form: solution for infusion, concentrate
Active substance Dosage carboplatin 10 mg/ml ATC: L01XA02
-
The medicinal product is used in the treatment of cancers, such as advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcomas. It may be administered in combination with other anticancer drugs.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage dacarbazine 100 mg ATC: L01AX04
-
The medicine is used in the treatment of advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcoma.
Dosage form: solution for infusion, powder for preparation of
Active substance Dosage dacarbazine 1000 mg ATC: L01AX04
-
The medicine is used to treat cancers such as advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcomas. It may be administered in combination with other anticancer medicines.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage dacarbazine 200 mg ATC: L01AX04
-
The medicine is used to treat cancers such as advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcomas.
Dosage form: solution for infusion, powder for preparation of
Active substance Dosage dacarbazine 500 mg ATC: L01AX04
-
The medicine is used in the treatment of breast cancer, advanced ovarian cancer, stomach cancer, small cell lung cancer, and superficial or very localized bladder cancer.
Dosage form: solution for injection
Active substance Dosage epirubicin hydrochloride 2 mg/ml ATC: L01DB03
-
This is an anticancer medicine used in the adjuvant and palliative treatment of colorectal cancer and breast cancer. It may be administered together with other anticancer medicines.
Dosage form: solution for injection
Active substance Dosage 5-fluorouracil 500 mg/10 ml ATC: L01BC02
-
The medicinal product is used in the treatment of active rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also used in cases of moderate to severe psoriasis, severe psoriatic arthritis, and mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 7.5 mg ATC: L01BA01
-
The medicine is used to treat active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis, moderate to severe psoriasis, psoriatic arthritis, and Crohn's disease (mild to moderate).
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 12.5 mg ATC: L01BA01
-
The medicine is used for the treatment of active rheumatoid arthritis in adults, polyarticular severe juvenile idiopathic arthritis, moderate and severe psoriasis, and severe psoriatic arthritis in adults, as well as mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 10 mg ATC: L01BA01
-
The medicine is used in the treatment of active rheumatoid arthritis in adults, the polyarticular form of severe juvenile idiopathic arthritis, moderate and severe psoriasis, psoriatic arthritis, and mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 15 mg ATC: L01BA01
-
The medicine is used for the treatment of rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also indicated for moderate and severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 17.5 mg ATC: L01BA01
-
The medicine is used for the treatment of active rheumatoid arthritis in adults, the polyarticular form of severe juvenile idiopathic arthritis, moderate and severe psoriasis, and severe psoriatic arthritis in adults, as well as mild to moderate Crohn's disease in adult patients.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 20 mg ATC: L01BA01
-
The drug is used in the treatment of rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also indicated for moderate to severe psoriasis, psoriatic arthritis, and mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 22.5 mg ATC: L01BA01
-
The medicine is used to treat active rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also intended for the treatment of moderate to severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 25 mg ATC: L01BA01
-
The medicine is used for the treatment of active rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also used in cases of moderate to severe psoriasis, psoriatic arthritis in adults, and mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 27.5 mg ATC: L01BA01
-
The medicine is used in the treatment of rheumatoid arthritis in adults and the polyarticular form of severe juvenile idiopathic arthritis. It is also indicated for moderate to severe psoriasis, psoriatic arthritis, and mild to moderate Crohn's disease.
Dosage form: solution for injection in a syringe
Active substance Dosage sodium methotrexate 30 mg ATC: L01BA01
-
It is used in the treatment of certain types of lung cancer (non-small cell lung cancer) and breast cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage vinorelbine 10 mg ATC: L01CA04
-
The medicine helps to destroy tumors. It is used in the treatment of ovarian cancer and small cell lung cancer (when a recurrence occurs after chemotherapy), as well as in the treatment of advanced cervical cancer when surgery or radiotherapy cannot be used.
Dosage form: solution for infusion, concentrate
Active substance Dosage topotecan 1 mg/ml ATC: L01XX17
-
The medicine helps to dissolve blood clots occurring in the lungs, deep veins, peripheral arteries (e.g., in the legs), as well as in central venous catheters and arteriovenous fistulas for hemodialysis.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 10000 j.m. ATC: B01AD04
-
The medicine helps to dissolve blood clots located in the lungs, deep veins, peripheral arteries, as well as in central venous catheters and arteriovenous fistulas for hemodialysis.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 50000 j.m. ATC: B01AD04
-
The medicine helps to dissolve blood clots located in the lungs, deep veins, peripheral arteries (e.g., in the legs), as well as in central venous catheters and arteriovenous fistulas for hemodialysis.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 100000 j.m. ATC: B01AD04
-
The medicine helps to dissolve blood clots located in the lungs, deep veins, peripheral arteries, as well as in central venous catheters and arteriovenous fistulas for hemodialysis.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 250000 j.m. ATC: B01AD04
-
The medicine helps to dissolve blood clots located in the lungs, deep veins, peripheral arteries, as well as in central venous catheters and arteriovenous fistulas for hemodialysis.
Dosage form: powder for preparation of solution for injection or infusion
Active substance Dosage urokinase 500000 mg ATC: B01AD04
-
It is used in the treatment of certain types of lung cancer and certain types of breast cancer in adults over 18 years of age.
Dosage form: capsules, soft gelatin
Active substance Dosage vinorelbine tartrate 27.7 mg ATC: L01CA04
-
The medicine is used to treat certain types of lung cancer and certain types of breast cancer in adults over 18 years of age.
Dosage form: capsules, soft gelatin
Active substance Dosage vinorelbine tartrate 41.55 mg ATC: L01CA04
-
This medicine is used to treat certain types of lung cancer and certain types of breast cancer in adults over 18 years of age.
Dosage form: capsules, soft gelatin
Active substance Dosage vinorelbine tartrate 110.8 mg ATC: L01CA04